SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-125058
Filing Date
2022-12-07
Accepted
2022-12-07 07:51:35
Documents
15
Period of Report
2022-12-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232121d1_8k.htm   iXBRL 8-K 26086
2 EXHIBIT 99.1 tm2232121d1_ex99-1.htm EX-99.1 14095
6 GRAPHIC tm2232121d1_8kimg001.jpg GRAPHIC 4789
7 GRAPHIC tm2232121d1_ex99-1img01.jpg GRAPHIC 2377
  Complete submission text file 0001104659-22-125058.txt   231079

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxxgf-20221207.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxxgf-20221207_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxxgf-20221207_pre.xml EX-101.PRE 22596
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2232121d1_8k_htm.xml XML 3432
Mailing Address 500 CUMMINGS CTR., SUITE 4550 BEVERLY MA 01915
Business Address 500 CUMMINGS CTR., SUITE 4550 BEVERLY MA 01915 800-215-1824
LexaGene Holdings Inc. (Filer) CIK: 0001450416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0228
Type: 8-K | Act: 34 | File No.: 000-56456 | Film No.: 221449140
SIC: 3841 Surgical & Medical Instruments & Apparatus